DEVELOPMENT OF RESISTANCE TO CHLORGUANIDE (PALUDRINE) DURING TREATMENT OF INFECTIONS WITH PLASMODIUM-CYNOMOLGI

被引:0
作者
SCHMIDT, LH
GENTHER, CS
FRADKIN, R
SQUIRES, W
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:382 / 398
页数:17
相关论文
共 50 条
  • [32] Extended clearance time after treatment of infections with Plasmodium malariae may not be indicative of resistance to chloroquine
    Collins, WE
    Jeffery, GM
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 67 (04) : 406 - 410
  • [33] CHARACTERIZATION OF <it>PLASMODIUM VIVAX</it> GENE EXPRESSION DURING CLINICAL INFECTIONS AND UPON CHLOROQUINE TREATMENT
    Serre, David
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04) : 651 - 651
  • [34] DEVELOPMENT OF RESISTANCE OF PLASMODIUM-FALCIPARUM TO CHLOROQUINE AND MEFLOQUINE IN BENIN DURING THE EIGHTIES
    CHIPPAUX, JP
    MASSOUGBODJI, A
    AKOGBETO, M
    JOSSE, R
    ZOHOUN, T
    SADELER, BC
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1990, 83 (03): : 320 - 329
  • [35] Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
    Huang, Po-Han
    Chen, Wen-Yin
    Chou, Sheng-Hua
    Wang, Fu-Der
    Lin, Yi-Tsung
    MICROBIOLOGY SPECTRUM, 2022, 10 (03):
  • [36] Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
    Fraile-Ribot, Pablo A.
    Cabot, Gabriel
    Mulet, Xavier
    Perianez, Leonor
    Martin-Pena, M. Luisa
    Juan, Carlos
    Perez, Jose L.
    Oliver, Antonio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (03) : 658 - 663
  • [37] Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies
    Muhammad Sajid Hamid Akash
    Kanwal Rehman
    Fareeha Fiayyaz
    Shakila Sabir
    Mohsin Khurshid
    Archives of Microbiology, 2020, 202 : 953 - 965
  • [38] Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies
    Akash, Muhammad Sajid Hamid
    Rehman, Kanwal
    Fiayyaz, Fareeha
    Sabir, Shakila
    Khurshid, Mohsin
    ARCHIVES OF MICROBIOLOGY, 2020, 202 (05) : 953 - 965
  • [39] How to avoid drug resistance during treatment and prevention of urinary tract infections
    Warzecha, Damian
    Pietrzak, Bronislawa
    Urban, Aleksandra
    Wielgos, Miroslaw
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2021, 20 (04): : 217 - 221
  • [40] Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections
    Koukoulioti, Eleni
    Brodzinski, Annika
    Mihm, Ulrike
    Sarrazin, Christoph
    Jung, Maria-Christina
    Schott, Eckart
    Fueloep, Balazs
    Schlosser, Beate
    Berg, Thomas
    van Boemmel, Florian
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (07) : 845 - 852